NCT02402361 (Neuropathic) is a clinical trial in Diabetic Neuropathy, sponsored by Rambam Health Care Campus.

Who is sponsoring NCT02402361?

NCT02402361 is sponsored by Rambam Health Care Campus.

What condition does NCT02402361 study?

NCT02402361 studies Diabetic Neuropathy.

Is NCT02402361 still recruiting?

NCT02402361 is currently completed. Last updated 20 May 2021.

Last reviewed 2021-05-20 · How we verify

NCT02402361: Neuropathic

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Understanding Risk Factors and Determinants for Neuropathic Pain

Completed Last updated 20 May 2021

What this trial tests

trial in Diabetic Neuropathy in 200 participants. Completed in 1 March 2021.

Timeline

1 April 2016

Primary endpoint
30 July 2020

1 March 2021

Quick facts

Lead sponsor	Rambam Health Care Campus
Status	Completed
Study type	OBSERVATIONAL
Enrollment	200
Start date	1 April 2016
Primary completion	30 July 2020
Estimated completion	1 March 2021
Sites	1 location across Israel

Conditions studied

Diabetic Neuropathy — all drugs for Diabetic Neuropathy →

Sponsor

Rambam Health Care Campus — full company profile →

Who can join

18 and older, any sex, with Diabetic Neuropathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Understanding risk factors and determinants for neuropathic pain.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

DOLORisk: study protocol for a multi-centre observational study to understand the risk factors and determinants of neuropathic pain.
Pascal MMV, Themistocleous AC, Baron R, Binder A, et al · · 2018 · cited 34× · PMID 30756091 · DOI 10.12688/wellcomeopenres.14576.2
Classification of painful or painless diabetic peripheral neuropathy and identification of the most powerful predictors using machine learning models in large cross-sectional cohorts.
Baskozos G, Themistocleous AC, Hebert HL, Pascal MMV, et al · · 2022 · cited 31× · PMID 35644620 · DOI 10.1186/s12911-022-01890-x
Electroencephalography functional connectivity-A biomarker for painful polyneuropathy.
Topaz LS, Frid A, Granovsky Y, Zubidat R, et al · · 2023 · cited 9× · PMID 36148823 · DOI 10.1111/ene.15575

Verify or expand the search:

Other recruiting trials for Diabetic Neuropathy

Currently open trials in the same condition.

NCT07394504 — Effects of Turning Based Dual Task Training on Balance and Mild Cognitive Impairment in Diabetic Peripheral Neuropathy · NA · recruiting
NCT07272993 — Effect of Golden Rice-Piper Crocatum Cookies on Neuropathy Prevention in Diabetes · NA · active not recruiting
NCT07036796 — Effect of Melatonin in Patients With Diabetic Peripheral Neuropathy · Phase 2 · recruiting
NCT06958302 — The Relation Between Diabetic Neuropathy and Muscle Mass in Type 2 Diabetes Mellitus Patients · recruiting
NCT06668623 — Effect of Reiki on Neuropathic Pain Severity and Sleep Quality in Patients With Diabetic Neuropathy · NA · recruiting

Other Rambam Health Care Campus trials

Trials by the same sponsor.

NCT07384013 — Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs · NA · recruiting
NCT06688253 — Intravenous Human IgG1 Fc Fragment (Efgartigimod) in Myasthenic Crisis · Phase 4 · not yet recruiting
NCT06235749 — Administration Of Calcium Gluconate for The Reduction of Blood Loss During Elective Cesarean Delivery · NA · recruiting
NCT06622902 — Influence of Flow Rate Change on CO2 Levels During High Flow Nasal Ventilation (HFNV) in Preterm Infants. · NA · recruiting
NCT05922111 — Cervical Ripening Balloon for 12 Hours vs. 1 Hour. · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02402361 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rambam Health Care Campus
Last refreshed: 20 May 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02402361.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing